Gaynes Bruce I, Singa Ramesh M, Schaab Gabriel, Sorokin Yevgeniva
Department of Ophthalmology, Rush University College of Medicine, Chicago, IL 60612, USA.
J Ocul Pharmacol Ther. 2007 Apr;23(2):196-201. doi: 10.1089/jop.2006.0122.
The aim of this study was to describe the cost considerations of multidose artificial tear products according to drop volume and the number of usable drops per bottle, based on a 45- versus 90-degree administration angle.
Densitometric assessment of the drop volume of five multidose artificial tear products of a 15-mL labeled bottle size in conjunction with predictive cost analysis.
The correlation between drop volume and density was not significant (Spearman correlation, P = 0.4500; alpha < 0.05). Overall, drop size ranged from 65.9 microL to a nadir of 30.8 microL, with a statistically significant difference (Student t test, P < 0.05) between 45- and 90-degree volumes for all but one product. Cost analysis demonstrated up to a $1.93 per bottle cost savings by the administration of drops at a 45- rather than a 90-degree bottle angle.
Products that provide a higher number of drops per dollar of product offer economic advantages that may not be otherwise discernible by the examination of the product retail price alone. Furthermore, it is shown that altering the angle of administration may, in general, result in significant economic ramifications in the use of multidose artificial tear products longitudinally.
本研究旨在根据滴体积和每瓶可用滴数,描述基于45度与90度给药角度的多剂量人工泪液产品的成本考量。
对15毫升标签瓶尺寸的五种多剂量人工泪液产品的滴体积进行光密度评估,并结合预测成本分析。
滴体积与密度之间的相关性不显著(Spearman相关性,P = 0.4500;α < 0.05)。总体而言,滴大小范围从65.9微升至最低点30.8微升,除一种产品外,所有产品在45度和90度体积之间存在统计学显著差异(Student t检验,P < 0.05)。成本分析表明,以45度而非90度的瓶角度给药,每瓶可节省高达1.93美元的成本。
每美元产品提供更多滴数的产品具有经济优势,仅通过检查产品零售价格可能无法辨别这些优势。此外,研究表明,一般而言,改变给药角度可能会在纵向使用多剂量人工泪液产品时产生重大经济影响。